Comprehensive Genomic Analysis Reveals the Prognostic Role of
CNV
LRRK2
cancer
mutations
prognostic
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
24 07 2020
24 07 2020
Historique:
received:
15
06
2020
revised:
14
07
2020
accepted:
22
07
2020
entrez:
30
7
2020
pubmed:
30
7
2020
medline:
2
4
2021
Statut:
epublish
Résumé
Genetic alterations of leucine-rich repeat kinase 2 (
Identifiants
pubmed: 32722212
pii: genes11080846
doi: 10.3390/genes11080846
pmc: PMC7465025
pii:
doi:
Substances chimiques
LRRK2 protein, human
EC 2.7.11.1
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Adv Neurobiol. 2017;14:241-264
pubmed: 28353288
Mov Disord. 2014 Sep;29(10):1325-6
pubmed: 25048644
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
BMC Syst Biol. 2018 Jan 10;12(1):3
pubmed: 29321020
Int J Cancer. 2013 May 1;132(9):2217-21
pubmed: 23047306
J Cell Physiol. 2019 Dec;234(12):22742-22752
pubmed: 31127628
Mol Brain. 2015 Sep 18;8:54
pubmed: 26384650
EMBO Rep. 2018 Jan 2;19(2):305-319
pubmed: 29295817
Front Cell Neurosci. 2017 May 11;11:125
pubmed: 28553204
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1439-44
pubmed: 21220347
J Cancer. 2019 Jan 1;10(1):51-60
pubmed: 30662525
Lancet. 2005 Jan 29-Feb 4;365(9457):410-2
pubmed: 15680455
PLoS Genet. 2014 Feb 20;10(2):e1004173
pubmed: 24586201
Brain Behav. 2017 Dec 07;8(1):e00858
pubmed: 29568677
Biochem Soc Trans. 2019 Dec 20;47(6):1581-1595
pubmed: 31769472
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):E4357-66
pubmed: 27357661
Mol Cancer. 2014 May 06;13:103
pubmed: 24885928
Lancet Oncol. 2012 Nov;13(11):1133-40
pubmed: 23084521
Biochem Soc Trans. 2017 Feb 8;45(1):155-162
pubmed: 28202669
J Clin Oncol. 2013 Jun 1;31(16):2024-8
pubmed: 23569312
J Neural Transm (Vienna). 2011 May;118(5):795-808
pubmed: 21552986
Lancet. 2005 Jan 29-Feb 4;365(9457):415-6
pubmed: 15680457
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
Oncotarget. 2011 Nov;2(11):886-91
pubmed: 22095441
Neuron. 2004 Nov 18;44(4):595-600
pubmed: 15541308
Mov Disord. 2010 Nov 15;25(15):2536-41
pubmed: 20818610
FASEB J. 2016 Jan;30(1):336-47
pubmed: 26396237
Hum Mol Genet. 2009 Nov 1;18(21):4022-34
pubmed: 19640926
Mov Disord. 2019 Sep;34(9):1392-1398
pubmed: 31348549
Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):255-9
pubmed: 20418034
Nat Med. 2015 Oct;21(10):1190-8
pubmed: 26366712
Oncogenesis. 2018 Mar 13;7(3):25
pubmed: 29540752
Mov Disord. 2014 May;29(6):750-5
pubmed: 24357540
Sci Transl Med. 2018 Jun 6;10(444):
pubmed: 29875204
PeerJ. 2015 Feb 19;3:e778
pubmed: 25737818
Int J Oncol. 2019 Jul;55(1):21-34
pubmed: 31180559
Nat Genet. 2008 Aug;40(8):955-62
pubmed: 18587394
Neurochem Res. 2014;39(3):576-92
pubmed: 23729298
Neurobiol Dis. 2018 Mar;111:26-35
pubmed: 29246723
Neuron. 2004 Nov 18;44(4):601-7
pubmed: 15541309
Nat Rev Neurol. 2020 Feb;16(2):97-107
pubmed: 31980808
J Neurochem. 1990 Mar;54(3):823-7
pubmed: 2154550
J Cell Physiol. 2020 Mar;235(3):3056-3068
pubmed: 31538341
N Engl J Med. 2009 Dec 31;361(27):2609-18
pubmed: 20018961
Lancet. 2005 Jan 29-Feb 4;365(9457):412-5
pubmed: 15680456
Ann Neurol. 2002 Mar;51(3):296-301
pubmed: 11891824
Curr Neuropharmacol. 2016;14(3):214-25
pubmed: 26517051
Neuroscience. 2008 Mar 18;152(2):429-36
pubmed: 18272292
Front Neurosci. 2020 Apr 28;14:376
pubmed: 32410948
Mol Neurodegener. 2019 Dec 21;14(1):49
pubmed: 31864390
Sci Transl Med. 2018 Jan 10;10(423):
pubmed: 29321258
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Oncogene. 2005 Apr 21;24(18):2929-43
pubmed: 15735718
Dig Dis Sci. 2020 Feb;65(2):500-508
pubmed: 31489563
Exp Cell Res. 2008 Jun 10;314(10):2055-65
pubmed: 18445495
Neurology. 2012 Mar 13;78(11):781-6
pubmed: 22323743
Adv Neurobiol. 2017;14:3-30
pubmed: 28353276
Expert Opin Ther Pat. 2020 Apr;30(4):275-286
pubmed: 32049564
Biochem Biophys Res Commun. 2013 Nov 29;441(4):862-6
pubmed: 24211199
Mov Disord. 2019 Apr;34(S1):S1-S19
pubmed: 30913575
Onco Targets Ther. 2018 Jan 31;11:609-618
pubmed: 29430186
J Cell Physiol. 2019 Nov;234(11):20980-20991
pubmed: 31102261